Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$455M |
| 2 |
AbbVie
ABBV
|
+$325M |
| 3 |
Capital One
COF
|
+$271M |
| 4 |
United Parcel Service
UPS
|
+$270M |
| 5 |
VF Corp
VFC
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.3B |
| 2 |
Lowe's Companies
LOW
|
+$528M |
| 3 |
NVIDIA
NVDA
|
+$400M |
| 4 |
Meta Platforms (Facebook)
META
|
+$374M |
| 5 |
Apple
AAPL
|
+$364M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 10.85% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
iQIYI
IQ
$1.3B
| $120K | ﹤0.01% |
14,945
-57,403
| -79% | -$595K |
|
3702
Vuzix
VUZI
$203M
| $120K | ﹤0.01% |
11,477
-480
| -4% | -$6.42K |
|
|
CBAY
3703
DELISTED
Cymabay Therapeutics
CBAY
| $120K | ﹤0.01% |
32,645
-1,705
| -5% | -$6.72K |
|
|
PMBC
3704
DELISTED
Pacific Mercantile Bancorp
PMBC
| $119K | ﹤0.01% |
12,907
-93
| -0.7% | -$805 |
|
3705
Xeris Biopharma Holdings
XERS
$1.38B
| $118K | ﹤0.01% |
48,200
-400
| -0.8% | -$1.16K |
|
|
HIX
3706
Western Asset High Income Fund II
HIX
$351M
| $117K | ﹤0.01% |
16,285
-11,539
| -41% | -$85.7K |
|
3707
inTEST
INTT
$169M
| $116K | ﹤0.01% |
+10,100
| New | +$134K |
|
3708
Verastem
VSTM
$502M
| $116K | ﹤0.01% |
3,125
+325
| +12% | +$11.9K |
|
3709
Amplify Energy
AMPY
$166M
| $115K | ﹤0.01% |
+21,642
| New | +$81.2K |
|
3710
Workhorse Group
WKHS
$33.6M
| $115K | ﹤0.01% |
5
+1
| +25% | +$30.3K |
|
3711
Eterna Therapeutics
ERNA
$3.98M
| $110K | ﹤0.01% |
+2
| New | +$173K |
|
|
BKCC
3712
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $107K | ﹤0.01% |
27,586
+2,715
| +11% | +$10.9K |
|
|
JHAA
3713
DELISTED
Nuveen Corporate Income 2023 Target Term Fund
JHAA
| $107K | ﹤0.01% |
10,833
-2,162
| -17% | -$21.5K |
|
|
CHMI
3714
Cherry Hill Mortgage Investment Corp
CHMI
$84.9M
| $106K | ﹤0.01% |
11,934
+167
| +1% | +$1.54K |
|
3715
Neurogene
NGNE
$664M
| $104K | ﹤0.01% |
717
+7
| +1% | +$1.07K |
|
|
MCBC
3716
DELISTED
Macatawa Bank Corp
MCBC
| $103K | ﹤0.01% |
12,748
-960
| -7% | -$7.85K |
|
3717
Atossa Therapeutics
ATOS
$21.6M
| $97K | ﹤0.01% |
1,990
+1,098
| +123% | +$63.9K |
|
|
BMTX
3718
DELISTED
BM Technologies, Inc.
BMTX
| $97K | ﹤0.01% |
10,878
-19,991
| -65% | -$205K |
|
3719
Amneal Pharmaceuticals
AMRX
$5.99B
| $96K | ﹤0.01% |
17,950
+100
| +0.6% | +$503 |
|
|
AUTL
3720
Autolus Therapeutics
AUTL
$498M
| $95K | ﹤0.01% |
+14,503
| New | +$91.6K |
|
3721
ProQR Therapeutics
PRQR
$243M
| $94K | ﹤0.01% |
11,200
-1,200
| -10% | -$7.84K |
|
3722
Gold Fields
GFI
$30B
| $92K | ﹤0.01% |
+11,286
| New | +$101K |
|
3723
RLX Technology
RLX
$2.44B
| $92K | ﹤0.01% |
+20,339
| New | +$111K |
|
3724
CEMIG Preferred Shares
CIG
$6.18B
| $91K | ﹤0.01% |
61,092
+1,575
| +3% | +$2.21K |
|
|
PGRE
3725
DELISTED
Paramount Group
PGRE
| $91K | ﹤0.01% |
10,066
-515
| -5% | -$4.77K |
|
Similar funds
Ameriprise's Q3 2021 Portfolio in Review
As of Q3 2021, Ameriprise held 4,040 positions worth $313B, down 3.2% from $323B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ameriprise's Q3 2021 filing shows 157 new, 1,612 increased, 1,952 reduced and 193 closed positions. Its largest new stake was Thoughtworks Holding, Inc. Common Stock: 2,971,244 shares worth $85.3M. The largest sale was Microsoft, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2021 buy was Thoughtworks Holding, Inc. Common Stock: 2,971,244 shares worth $85.3M.
- Ameriprise added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2021, an estimated $455M increase.
- Ameriprise's biggest Q3 2021 reduction was Microsoft, cutting an estimated $1.3B.
- Ameriprise fully exited Maxim Integrated Products in Q3 2021, selling an estimated $282M.
- Ameriprise's ten largest holdings make up 15% of its $313B portfolio in Q3 2021.
- Ameriprise opened 157 new positions and closed 193 in Q3 2021.
- Ameriprise's portfolio value fell 3.2% quarter-over-quarter to $313B.
Based on Ameriprise's 13F filing for Q3 2021, filed 15 Nov 2021.